Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.47%
1,101.16
-5.21
-0.47%
—1,106.361,105.681,109.291,096.52——
SIXC
Communications
SIXC
Communications
SIXC
+0.46%
613.11
+2.82
+0.46%
—610.29610.29616.60610.29——
SIXE
Energy
SIXE
Energy
SIXE
+0.89%
1,222.05
+10.83
+0.89%
—1,211.221,211.011,221.951,208.50——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.38%
1,757.37
+6.66
+0.38%
—1,750.711,753.101,762.131,743.30——
SIXM
Financials
SIXM
Financials
SIXM
+0.71%
632.66
+4.49
+0.71%
—628.17629.38634.09629.38——
SIXR
Staples
SIXR
Staples
SIXR
+0.31%
857.22
+2.65
+0.31%
—854.57855.71860.09855.45——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.41%
215.97
-0.90
-0.41%
—216.87216.87217.79215.51——
SIXT
Technology
SIXT
Technology
SIXT
+1.43%
3,612.96
+51.02
+1.43%
—3,561.943,571.443,628.583,562.15——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.35%
906.51
+3.20
+0.35%
—903.31903.26906.58901.18——
SIXV
Health care
SIXV
Health care
SIXV
-0.14%
1,479.44
-2.10
-0.14%
—1,481.541,482.481,488.461,474.18——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.07%
2,401.52
+1.57
+0.07%
—2,399.952,404.452,418.812,398.09——
GENB:NASDAQ
Generate Biomedicines Inc
$15.74
-2.93%
(-0.47) 1D
May 14, 2:53:47 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GENB...
Open
$16.43
High
$16.59
Low
$15.68
Mkt. cap
2.02B
Avg. vol.
333.26K
Volume
223.18K
52-wk high
$16.75
52-wk low
$11.00
EPS
-$1.96
No. of employees
312
News stories
From sources across the web
Profile
Generate:Biomedicines is a biotechnology company founded in 2018 and headquartered in Somerville, Massachusetts. It specializes in using machine learning to design and optimize proteins for therapeutic applications, with a focus on immunology, oncology, and infectious diseases. Wikipedia
About Generate Biomedicines Inc
CEO-
Employees312
Founded2018
HeadquartersSomerville, Massachusetts, United States
SectorBiotechnology
Websitegeneratebiomedicines.com
Last report
May 7, 2026
Fiscal Period
Q1 2026
EPS / Est. (USD)
-$1.07 / -$0.48
-120.62%miss
Revenue / Est. (USD)
7.22M / 4.69M
+54.11%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Mar 2026
Revenue
8.82M
7.22M
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
46.82M
57.81M
Total research and development expenses
-
-
Selling, general, and admin expenses
10.15M
13.52M
Operating expense
56.97M
71.34M
Total operating expenses
56.97M
71.34M
Operating income
-48.15M
-64.11M
Other non operating income
-
-363.00K
EBT including unusual items
-44.26M
-61.69M
EBT excluding unusual items
-44.26M
-61.69M
Income tax expense
56.00K
28.00K
Effective tax rate
-0.13%
-0.05%
Other operating expenses
-
-
Net income
-41.68M
-61.45M
Net profit margin
-472.73%
-850.58%
Earnings per share
-
-1.07
Interest and investment income
4.28M
2.91M
Interest expense
-368.00K
-182.00K
Net interest expenses
3.91M
2.73M
Depreciation and amortization charges
-
-
EBITDA
-44.74M
-60.84M
Gain or loss from assets sale
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer